IV contrast extravasation is a not uncommon complication in the performance IV contrast enhanced CT examinations. In this accredited Expert Forum Webcast, we will review the different complications related to IV contrast administration. This will be followed by analysis of different factors that contribute to IV contrast-extravasation and subsequent discussion of best practices that can reduce the incidence of IV contrast extravasation. A novel method which reduced contrast extravasation by over 50% will also be presented.
Following the presentation questions from the audience were addressed in a moderated Q&A session.
CME Effective Date: July 10, 2019
CME Expiration Date: July 9, 2021
CE Effective Date: July 19, 2019
CE Expiration Date: June 30, 2021
Format: Self Instructional - Audio Visual with Slides
One (1) AMA/PRA Category 1 CME Credit™
One (1) ARRT Category A CE Credit.
One (1) AHRA CRA Credit
Estimated Completion Time: 1 hour
This program is supported through an unrestricted educational grant from Bracco Diagnostics, Inc.
This program is intended for: Radiologists, Other MD's, Radiologic Technologists, Radiology Administrators and related Imaging Professionals.
There is no cost to participate in this program.
Upon completion of this CME activity the healthcare provider should be able to:
No special educational preparation is required for this CME/CE Activity!
Ryan K. Lee, MD, MBA
Clinical Associate Professor SKMC at Thomas Jefferson University
Vice Chair of Quality and Safety
Section Chief of Neuroradiology
Einstein Healthcare Network
Dr. Ryan K. Lee, MD, MBA, MRMD is Clinical Associate Professor at the Sydney Kimmel College at Thomas Jefferson University. He is the Vice Chair of Quality and Safety, Section Chief of Neuroradiology, and the Magnetic Resonance Medical Director in the Department of Radiology. His areas of expertise include radiation management in imaging, radiology clinical decision support, and MRI Safety. He is known for his work not only in CT radiation dose reduction, but also in the reduction of variance in radiation dose. An authority on quality in radiology, he serves on several quality and safety committees in the Einstein Healthcare Network.
Dr. Lee has expertise in hospital and physician reimbursement, and as Chair of the MACRA committee at Einstein is responsible for developing strategies in the MIPS and APM environment. He has extensive experience in the implementation of radiology clinical decision support, and has given numerous lectures regarding its benefits. He is a member of ACR Appropriateness Criteria Neurological Imaging Subcommittee, ACR MACRA committee, ACR Economics Subcommittee on Neuroradiology, and ACR GSER Quality and Safety Committee. He serves on the board for the Pennsylvania Radiological Society and the Philadelphia Roentgen Ray Society.
Dr. Lee graduated from Cornell University with a Bachelor of Arts, and attained his medical degree at Drexel School of Medicine. He completed his residency in Diagnostic Radiology at the University of Rochester and fellowship in Neuroradiology at the University of Pennsylvania. He is a Diplomate of the American Board of Radiology and has a Certificate of Added Qualification in Neuroradiology. He holds a Masters of Business Administration degree from the Simon School at the University of Rochester.
IAME requires everyone who is in a position to control the content of a CE/CME activity to disclose all relevant financial relationships with any commercial interest. This information is utilized to 1) determine if a conflict exists, 2) resolve the conflict by initiating a content validation process, and 3) advise learners of this information. Any individual who refuses to (or chooses not to) disclose relevant financial relationships will be disqualified from participating as an instructor, planner or manager and cannot have control of or responsibility for the development, management, presentation or evaluation of a CE/CME activity certified by IAME.
Dr. Lee discloses he is a member of the Bayer Healthcare Speaker's Bureau
No individual at IAME who had control over the content of this program has relationships with Bracco Diagnostics, Inc. or any other commercial supporter.
The Institute for Advanced Medical Education (IAME) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Institute for Advanced Medical Education (IAME) designates this enduring material for a maximum of 1 AMA/PRA Category 1 CME Credits.™ Physicians should only claim credit commensurate with the extent of their participation in the activity.
Radiologic Technologists:(Pending Approval)
This course meets all criteria and has been approved by the AHRA, The Association for Medical Imaging Management for One (1) ARRT Category A CE Credit.
Radiology Administrators:(Pending Approval)
This course meets all CRA renewal credit criteria and has been approved for one (1) continuing education credit in the following CRA domains: Asset Resource Management (AM) and Operations Management (OM).
For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board or other credentialing organization.
To receive CME credits for participating in this CME activity you must successfully complete the online post examination with a passing score of 70% or higher.
To receive CE credits for participating in this CE activity you must successfully complete the online post examination with a passing score of 80% or higher.
Online examinations return an immediate grade report. Upon receiving a passing score click Continue and complete the evaluation form. To view and print your Statement of Credit click the Print/View Certificate button displayed from within your MyAR Archives page.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.